该项收购完成后,Cambrex公司将获得Avista公司包括从原料药、药品开发、环化核苷酸制造,到独立分析、微生物测验以及固态科学等多项服务,同时将Avista的4个制药站点纳入其生...查看全文
琬麟2015-02-07 09:21
$凯姆布雷克斯(CBM)$ EAST RUTHERFORD, N.J., Feb. 6, 2015 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that it has initiated the second significant expansion of its Charles City, Iowa facility in less than three years. Strong continu...查看全文
$凯姆布雷克斯(CBM)$ 内部交易: 2018-08-06,EVP & COO,Cavanagh Shawn ,期权,37899普通股, $28.68
$凯姆布雷克斯(CBM)$ 内部交易: 2018-08-06,VP, General Counsel,Hanley Samantha ,卖出,27500普通股, $62.64
$凯姆布雷克斯(CBM)$ 内部交易: 2018-08-06,VP, General Counsel,Hanley Samantha ,期权,27500普通股, $34.26
$凯姆布雷克斯(CBM)$ 内部交易: 2018-08-06,总裁 & CEO,KLOSK STEVEN M ,卖出,80000普通股, $62.45
$凯姆布雷克斯(CBM)$ 内部交易: 2018-08-01,总裁 & CEO,KLOSK STEVEN M ,卖出,55000普通股, $62.46
$凯姆布雷克斯(CBM)$ 内部交易: 2018-08-01,总裁 & CEO,KLOSK STEVEN M ,期权,55000普通股, $16.99
$凯姆布雷克斯(CBM)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-08-02 AccNo: 0001564590-18-018670 Size: 8 MB 网页链接
$凯姆布雷克斯(CBM)$ 8-K - Current report Filed: 2018-08-02 AccNo: 0001193125-18-235577 Size: 228 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$凯姆布雷克斯(CBM)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-08-02 AccNo: 0001564590-18-018670 Size: 8 MB 网页链接
$凯姆布雷克斯(CBM)$ 8-K - Current report Filed: 2018-08-02 AccNo: 0001193125-18-235577 Size: 228 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接